| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 38 | 63.3% | -0.34 | 30 | 62.5% |
| AL(R) | 21 | 35.0% | -0.22 | 18 | 37.5% |
| CentralBrain-unspecified | 1 | 1.7% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ORN_VM6l | % In | CV |
|---|---|---|---|---|---|
| lLN2F_b (R) | 2 | GABA | 4 | 20.5% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 2.5 | 12.8% | 0.6 |
| lLN2F_a (R) | 2 | unc | 2 | 10.3% | 0.0 |
| ORN_VM6m | 3 | ACh | 1.5 | 7.7% | 0.0 |
| ORN_VC3 | 2 | ACh | 1 | 5.1% | 0.0 |
| ORN_VM6l | 2 | ACh | 1 | 5.1% | 0.0 |
| lLN2P_b (R) | 2 | GABA | 1 | 5.1% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 1 | 5.1% | 0.0 |
| il3LN6 (L) | 1 | GABA | 0.5 | 2.6% | 0.0 |
| lLN2X02 (R) | 1 | GABA | 0.5 | 2.6% | 0.0 |
| lLN2X12 (R) | 1 | ACh | 0.5 | 2.6% | 0.0 |
| ORN_VC1 | 1 | ACh | 0.5 | 2.6% | 0.0 |
| CB2908 (R) | 1 | ACh | 0.5 | 2.6% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 0.5 | 2.6% | 0.0 |
| ORN_VM6v | 1 | ACh | 0.5 | 2.6% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.5 | 2.6% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.5 | 2.6% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.5 | 2.6% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.5 | 2.6% | 0.0 |
| downstream partner | # | NT | conns ORN_VM6l | % Out | CV |
|---|---|---|---|---|---|
| VM6_adPN (L) | 1 | ACh | 7 | 12.8% | 0.0 |
| VM6_adPN (R) | 1 | ACh | 5.5 | 10.1% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 4 | 7.3% | 0.0 |
| lLN2P_b (R) | 4 | GABA | 3.5 | 6.4% | 0.5 |
| lLN2F_b (R) | 2 | GABA | 3 | 5.5% | 0.3 |
| ORN_VM6l | 3 | ACh | 3 | 5.5% | 0.4 |
| il3LN6 (L) | 1 | GABA | 2.5 | 4.6% | 0.0 |
| lLN2X12 (L) | 1 | ACh | 2.5 | 4.6% | 0.0 |
| M_lvPNm46 (L) | 1 | ACh | 2.5 | 4.6% | 0.0 |
| lLN2F_a (R) | 1 | unc | 2 | 3.7% | 0.0 |
| ORN_VC1 | 3 | ACh | 1.5 | 2.8% | 0.0 |
| VM6_lvPN (L) | 1 | ACh | 1 | 1.8% | 0.0 |
| vLN25 (L) | 1 | Glu | 1 | 1.8% | 0.0 |
| lLN1_bc (R) | 1 | ACh | 1 | 1.8% | 0.0 |
| M_lvPNm47 (L) | 1 | ACh | 1 | 1.8% | 0.0 |
| v2LN5 (L) | 1 | ACh | 1 | 1.8% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 1 | 1.8% | 0.0 |
| lLN2X02 (L) | 2 | GABA | 1 | 1.8% | 0.0 |
| M_lvPNm24 (L) | 1 | ACh | 1 | 1.8% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 1 | 1.8% | 0.0 |
| ORN_VC3 | 1 | ACh | 0.5 | 0.9% | 0.0 |
| vLN27 (L) | 1 | unc | 0.5 | 0.9% | 0.0 |
| M_adPNm5 (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| M_lvPNm46 (R) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| VP2+Z_lvPN (R) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2T_b (R) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| VP1m+VP2_lvPN1 (R) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| ORN_VM6v | 1 | ACh | 0.5 | 0.9% | 0.0 |
| M_l2PN3t18 (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| ALBN1 (L) | 1 | unc | 0.5 | 0.9% | 0.0 |
| ORN_VM6m | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2X04 (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.5 | 0.9% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.5 | 0.9% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2T_c (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2F_a (L) | 1 | unc | 0.5 | 0.9% | 0.0 |
